Thromb Haemost 1977; 37(03): 380-395
DOI: 10.1055/s-0038-1649246
Original Article
Schattauer GmbH

Enzymatic Properties of 5′-AMP[*] Deaminase in Platelet Lysates

H Holmsen
1   Institute for Thrombosis Research, University of Oslo, Oslo-1, Norway
2   Specialized Center for Thrombosis Research, Temple University Philadelphia, Pennsylvania, U.S.A.
,
A.-C Østvold
1   Institute for Thrombosis Research, University of Oslo, Oslo-1, Norway
2   Specialized Center for Thrombosis Research, Temple University Philadelphia, Pennsylvania, U.S.A.
,
M. A Pimentel
1   Institute for Thrombosis Research, University of Oslo, Oslo-1, Norway
2   Specialized Center for Thrombosis Research, Temple University Philadelphia, Pennsylvania, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 30 September 1976

Accepted 20 March 1977

Publication Date:
03 July 2018 (online)

Summary

Metabolic ATP is converted to hypoxanthine during platelet secretion, metabolic shock and slowly in the resting state. This conversion involves deamination of 5′-AMP to 5′-IMP which has been studied by incubating 5′-AMP (3–40 μM) with human platelet lysates and quantifying the metabolites formed. Deamination occurred only when EDTA was present or endogenous ATP absent, showing that 5’-AMP deaminase (EC 3.5.4.6) was the only enzyme attacking AMP. EDTA stimulated AMP deamination, probably by removal of endogenous heavy metals which were powerful inhibitors of deamination. The experiments were therefore performed with EDTA. 5′-AMP deaminase was soluble, and had optimal activity at pH 6.5; however, the rate of AMP deamination was highly dependent on the type of buffer used. Km was 0.92 × 10–3M and Vmax was 0.26 μmoles/min x mg protein. The deamination required presence of monovalent cation with Li+ = Na+ >K+ >NH4 +, a sequence distinctly different from that seen with erythrocyte and muscle deaminase. 50 mM Na+ gave maximal activity with [math]. Tris+ and K+ were competitive inhibitors with respect to Na+, a feature not reported for the enzyme from other tissues. Above 60 mM K+ there was no effect by Na+ (0–100 mM). PPi, GTP, ITP, CTP and UTP gave greater inhibition than Pi and phospho-esters. Unlike AMP deaminase from other tissues, the platelet enzyme was insensitive to fluoride. ATP counteracted Pi and GTP inhibition and activated with or without Na+; ATP-and Na+-activation were additive. The activity increased as the adenylate energy charge was lowered, but was linearly related to the AMP concentration, thus in sharp contrast to deaminase from the liver. It is suggested that in the intact platelet AMP deamination is regulated chiefly through variations in the AMP level and not likely through variations in the ATP/Pi ratio.

* AMP, ADP and ATP = 5′-adenosine monophosphate, diphosphate and triphosphate, respectively. IMP and ITP = 5′-inosine mono- and triphosphate. GDP and GTP = 5′-guanosine diphosphate and -triphosphate. UTP = 5′-uridine triphosphate; CTP = 5′-cytidine triphosphate. Pi = inorganic orthophosphate; PPi = inorganic pyrophosphate; EDTA = ethylene diaminotetraacetate.


 
  • References

  • 1 Askari A. Erythrocytes: 5’-adenylic acid deaminase requirement for ammonia or monovalent metal ion. Science 1963; 141: 44
  • 2 Askari A. Effect of adenosine triphosphate and monovalent cations on brain 5’-adenylic acid deaminase. Nature 1964; 202: 185
  • 3 Askari A, Rao S. N. Regulation of AMP deaminase by 2. 3-dephosphoglyceric acid: A possible mechanism for the control of adenine nucleotide metabolism in human erythrocytes. Biochimica Biophysica Acta 1968; 151: 198
  • 4 Atkinson M. R, Murray A. W. Regulation of adenylate deaminase from Ehrlich ascitestumor cells by a phosphonate analogue of adenosine triphosphate. Biochemical Journal 1967; 104: 10C
  • 5 Chapman A. G, Atkinson D. E. Stabilization of adenylate energy charge by the adenylate deaminase reaction. Journal of Biological Chemistry 1973; 248: 8309
  • 6 Chen P. S, Torabara T. Y, Warner H. Microdetermination of phosphorus. Analytical Chemistry 1956; 28: 1756
  • 7 Day H. J, Holmsen H, Hovig T. Subcellular particles of human platelets. A biochemical and electromicroscopic study with particular reference to the influence of fractionation techniques. Scandinavian Journal of Haematology Suppl 1969; 7: 1
  • 8 Dingle J. R, Hines J. A. Extraction and some properties of adenosine 5’-monophosphate aminohydralase from prerigor and postrigor muscle of cod. Journal of the Fisheries Research Board of Canada 1967; 24: 1717
  • 9 Foley B, Johnson S. A, Hackely B, Smith Jr. J. R, Halsted J. A. Zinc content of human platelets. Proceeding of the Society of Experimental Biology and Medicine 1968; 128: 265
  • 10 Gaintner J. R, Jackson D. P, Maynert E. W. The action of thrombin on platelet 5-hydroxytryptamine. Bulletin of the Johns Hopkins Hospital 1964; 111: 185
  • 11 Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature 1964; 202: 765
  • 12 Henry H, Chilson O. P. AMP-deaminases from avian brain and muscle: Catalytic and immunological differences. Comparative Biochemistry and Physiology 1969; 29: 301
  • 13 Holmsen H. Changes in the radioactivity of P32-labelled acid soluble organophosphates in blood platelets during collagen and adenosine diphosphate induced platelet aggregation. Scandinavian Journal of Clinical and Laboratory Investigation 1965; 17: 537
  • 14 Holmsen H, Day H. J. Adenine nucleotides and platelet function. Series Haematologica 1971; 4: 28
  • 15 Holmsen H, Day H. J, Storm E. Adenine nucleotide metabolism of blood platelets. VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochimica Biophysica Acta 1969; a 186: 254
  • 16 Holmsen H, Day H. J, Pimentel M. A. Adenine nucleotide metabolism of blood platelets V. Subcellular localization and kinetics of some related enzymes. Biochimica Biophysica Acta 1969; b 186: 244
  • 17 Holmsen H, Day H. J, Setkowsky C. A. Secretory mechanisms: Behaviour of adenine nucleotides during platelet release reaction induced by adenosine diphosphate and adrenaline. Biochemical Journal 1972; 129: 67
  • 18 Holmsen H, Rozenberg M. C. Adenine nucleotide metabolism of blood platelets I. Adenosine kinase and nucleotide formation from exogenous adenosine and AMP. Biochimica Biophysica Acta 1968; 755: 326
  • 19 Holmsen H, Setkowsky C. A, Day H. J. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. The role of metabolic ATP levels in primary aggregation, secondary aggregation and shape change of human platelets. Biochemical Journal 1974; 144: 385
  • 20 Ireland D. M. Effect of thrombin on the radioactive nucleotides of human washed platelets. Biochemical Journal 1967; 105: 857
  • 21 Kattlove H. Platelet ATP in ADP-induced aggregation. American Journal of Physiology 1974; 266: 325
  • 22 Kerby G. P, Taylor S. M. The role of human platelets and plasma in the metabolism of adenosine diphosphate and monophosphate added in vitro. Thrombosis et Diathesis Haemorrhagica 1964; 12: 500
  • 23 Kimmel J. R, Smith E. L. Crystalline papin I. Preparation, specificity, and activation. Journal of Biological Chemistry 1954; 207: 625
  • 24 Lee Y. P. 5’-Adenylic acid deaminase III. Properties and kinetic studies. Journal of Biological Chemistry 1959; 227: 999
  • 25 Lee Y. P, Wang M. H. Studies of the nature of the inhibitory action of inorganic phosphate, fluoride, and detergents on 5’-adenylic acid deaminase activity and on the activation by adenosine triphosphate. Journal of Biological Chemistry 1968; 243: 2206
  • 26 Lopaciuk S, Solum N. O. Bovine platelet proteins I. Soluble proteins studied by Immunoelectrophoresis and Polyacrylamide disc electrophoresis. Thrombosis et Diathesis Haemorrhagica 1969; 21: 409
  • 27 Makarewicz W, Mackowiak E. Adenosine-5’-monophosphate aminohydrolase of human placenta. Acta Biochimica Polinski 1971; 18: 135
  • 28 Mendicino J, Muntz J. A. The activation of adenosine triphosphate on brain adenylic deaminase. Journal of Biological Chemistry 1958; 233: 178
  • 29 Murer E.H. Clot retraction energy metabolism of platelets. Effect and mechanism of inhibitors. Biochimica Biophysica Acta 1969; 172: 266
  • 30 Newsholme E. A, Start C. (eds) Regulation in Metabolism. Wiley and Sons; New York: 1973: 13-17.
  • 31 Nikiforuk G, Colowick S. P. The purification and properties of 5-adenylic acid deaminase from muscle. Journal of Biological Chemistry 1956; 219: 119
  • 32 Raggl A, Ranieri M, Taponeco G, Ronca-Testoni S, Ronca G, Rossi C. A. Interaction of rat muscle AMP aminohydrolase with chelating agents and metal ions. FEBS Letters 1970; 10: 101
  • 33 Raggi A, Ronca-Testoni S, Ronca G. Muscle AMP aminohydrolase II. Distribution of AMP aminohydrolase, myokinase and creatine kinase activities in skeletal muscle. Biochimica Biophysica Acta 1969; 178: 619
  • 34 Razin A, Maher J. The allosteric nature and regulatory function of AMP deaminase in nucleotide metabolism. Journal of Medical Science 1966; 2: 614
  • 35 Ronca G, Raggi A, Ronca-Testoni S. Muscle AMP aminohydrolase I. Some regulatory properties of rat skeletal muscle enzyme. Biochimica Biophysica Acta 1968; 167: 626
  • 36 Sammons D. W, Henry H, Chilson O. P. Effect of salts on inhibition of chicken muscle adenosine monophosphate deaminase by phosphate esters and inorganic phosphate. Effect of 5,5’-di-thiobis (2-nitrobenzoic acid) on enzyme activity and inhibition by 2,3-diphosphoglyceric acid. Journal of Biological Chemistry 1970; 245: 2109
  • 37 Setlow B, Lowenstein J. M. Adenylate deaminase II. Purification and some regulatory properties of the enzyme from calf brain. Journal of Biological Chemistry 1967; 242: 607
  • 38 Smiley K. L, Suelter C. H. Univalent cations as allosteric activators of muscle adenosine 5’-phosphate deaminase. Journal of Biological Chemistry 1967; 242: 1980
  • 39 Smith L. D, Kizer D.E. Purification and properties of rat liver AMP deaminase. Biochimica Biophysica Acta 1969; 191: 415
  • 40 Tomozawa Y, Wolfenden R. Binding of guanosine triphosphate and adenosine triphosphate by rabbit muscle adenosine monophosphate deaminase. Biochemistry 1970; 9: 3400
  • 41 Tonca-Testoni S, Raggi A, Ronca G. Muscle AMP aminohydrolase 3. A comparative study on the regulatory properties of skeletal muscle enzyme from various species. Biochimica Biophysica Acta 1970; 198: 101
  • 42 Weil-Malherbe H, Green R. H. Ammonia formation in brain II. Brain adenylic deaminase. Biochemical Journal 1955; 61: 218
  • 43 Wood T. Breakdown of adenosine triphosphate by muscle preparations in the presence of perchloric acid. Analytical Biochemistry 1971; 43: 107
  • 44 Zielke C. L, Suelter C. H. IV. 5’-Adenylic acid aminohydrolase. The Enzymes 1971; a 4: 47
  • 45 Zielke C. L, Suelter C. H. Substrate specificity and aspects of deamination catalyzed by rabbit muscle 5’-adenylic acid aminohydrolase. Journal of Biological Chemistry 1971; 246: 1313
  • 46 Zydowo M, Makarewicz W, Uminastowski J, Purzycka J. Temperature dependence of AMP deamination catalysed by muscle extracts from hemeothermic and Poikilothermic animals. Acta Biochimica Polinski 1965; 12: 319